Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Celularity (CELU) EPS (Basic) (2020 - 2025)

Celularity has reported EPS (Basic) over the past 6 years, most recently at -$0.88 for Q3 2025.

  • Quarterly results put EPS (Basic) at -$0.88 for Q3 2025, down 20.55% from a year ago — trailing twelve months through Sep 2025 was -$3.33 (down 172.95% YoY), and the annual figure for FY2024 was -$2.64, up 76.04%.
  • EPS (Basic) for Q3 2025 was -$0.88 at Celularity, up from -$1.02 in the prior quarter.
  • Over the last five years, EPS (Basic) for CELU hit a ceiling of $1.08 in Q4 2022 and a floor of -$4.98 in Q3 2023.
  • Median EPS (Basic) over the past 5 years was -$0.73 (2024), compared with a mean of -$1.08.
  • Biggest five-year swings in EPS (Basic): soared 142.86% in 2021 and later tumbled 16700.0% in 2023.
  • Celularity's EPS (Basic) stood at $0.51 in 2021, then surged by 111.76% to $1.08 in 2022, then decreased by 22.22% to $0.84 in 2023, then crashed by 170.24% to -$0.59 in 2024, then plummeted by 49.15% to -$0.88 in 2025.
  • The last three reported values for EPS (Basic) were -$0.88 (Q3 2025), -$1.02 (Q2 2025), and -$0.84 (Q1 2025) per Business Quant data.